GL1X · GenesisL1 explorer

MolNFT v1 · #65152 · protein

HCV NS5B polymerase in complex with 1,5 benzodiazepine inhibitor (R)- 11D

3GOL · RNA-directed RNA polymerase: “HCV NS5B polymerase in complex with 1,5 benzodiazepine inhibitor (R)- 11D”. X-ray diffraction, 2 ligands (XND, MG), 13 pockets (best druggability 0.80). MolNFT v1 #65152 on GenesisL1: 3D structure…

PDB
3GOL
Type
protein
Length
1,116 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
RNA-directed RNA polymerase
EC
2.7.7.48
UniProt
O92972
Ligands
XND, MG
Pockets
13 · best druggability 0.80

Structure

x-ray diffraction · 2 distinct chains · 49% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARNA-directed RNA polymerase (EC 2.7.7.48)protein55749% helix, 15% strandO92972
BRNA-directed RNA polymerase (EC 2.7.7.48)protein55949% helix, 15% strandO92972

Ligands and binding sites

  • XND · (11R)-10-acetyl-11-(2,4-dichlorophenyl)-6-hydroxy-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one · ligand · 2 copies · chains A, B
  • MG · Magnesium ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

13 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111690.800.8284XND, MG
29940.800.8176XND, MG
311300.720.76100empty
4900.540.8516empty
51140.460.7916empty

Interfaces

1 interface between chains.

  • A–B · 266 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 3GOL · HCV NS5b polymerase in complex with 1,5 benzodiazepine inhibitor (R)-11d · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.